Previous studies have implicated the JAK2/STAT3 signaling pathway and downstream IL-6 in uric acid-induced kidney injury, highlighting potential strategies for preventing and treating hyperuricemia-associated kidney damage. This evidence concerns the gene JAK2 and hyperuricemia.